Testing effectiveness (Phase 2)Ended earlyNCT03846193
What this trial is testing
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD
Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+4 more
Gyroscope Therapeutics Limited 56